At RSNA 2023, RapidAI revealed groundbreaking advancements, including the innovative Rapid Edge Cloud platform, cutting-edge non-contrast CT imaging solutions, and expansion into Japan. These milestones mark RapidAI’s commitment to revolutionizing healthcare through advanced AI-driven technology. By introducing novel solutions like Edge Cloud and pioneering non-contrast CT imaging, RapidAI aims to elevate clinical decision-making and patient care standards globally. This significant unveiling sets a new standard in healthcare innovation, showcasing RapidAI’s dedication to enhancing patient outcomes and transforming the landscape of clinical care across diverse medical conditions.
RapidAI, a frontrunner in the realm of digital health, recently unveiled groundbreaking advancements and international expansion at RSNA 2023, marking a pivotal moment in their pursuit of cutting-edge clinical solutions. This global leader specializes in harnessing artificial intelligence (AI) and technological workflows to combat critical neurovascular, trauma, cardiac, and vascular conditions. The significant milestones achieved by RapidAI include the introduction of pioneering advancements in clinical AI, international expansion into Japan, and the development of a revolutionary healthcare platform, Rapid Edge Cloud.
The cornerstone of this announcement is the launch of Rapid Edge Cloud, an innovative AI-driven healthcare platform that stands out for its unique hybrid architecture combining both cloud and on-premise capabilities. This platform has been meticulously crafted to deliver unparalleled speed, security, and flexibility, ensuring seamless integration with hospital systems and third-party applications. It’s important to note that the availability of Rapid Edge Cloud may vary across different countries.
A noteworthy feat for RapidAI was the attainment of Class III Shonin clearance in Japan, a pivotal step as Japan stands as the second largest stroke market globally. RapidAI is now the exclusive advanced stroke imaging platform sanctioned for supporting mechanical thrombectomy determination in Japan. Its distinct MR-based perfusion platform places RapidAI in a prime position to cater to the intricate imaging needs of Japanese clinicians.
Another breakthrough introduced by RapidAI is its suite of AI-powered non-contrast CT solutions for stroke assessment. Comprising Rapid NCCT Stroke, Rapid ASPECTS, Rapid Hypodensity, Rapid Hyperdensity, and Rapid SDH, this suite is the sole non-contrast solution available in the market. It facilitates the identification of suspected stroke cases upon the initial CT scan, significantly slashing the time required for decision-making and treatment initiation. This innovation holds the promise of significantly improving patient outcomes.
Moreover, RapidAI boasts a remarkable milestone of publishing over 120 papers in 2023 alone, showcasing the platform’s superior clinical validation and reinforcing its position as a pioneering force in the field.
Karim Karti, CEO of RapidAI, emphasized their relentless efforts in preparation for further innovations and expansions into new disease realms while celebrating a year marked by significant accomplishments. Karti highlighted the profound impact of their breakthrough AI and the Edge Cloud technology platform, emphasizing their potential to revolutionize care delivery across various diseases.
The unique feature of Rapid Edge Cloud lies in its highly adaptable hybrid nature, enabling the continuity of on-premise AI services even in scenarios where hospital connectivity to the cloud is disrupted. This ensures uninterrupted delivery of life-saving care. Furthermore, the Edge Cloud platform facilitates seamless integration with third-party AI systems and algorithms, presenting a comprehensive solution aligned with the stringent requirements of modern healthcare, including privacy, scalability, and rapid information dissemination.
Dr. Vivek Yedavalli, Chief of Neuroradiology at Johns Hopkins Bayview Medical Center, commended RapidAI for not only enhancing care standards with its new platform but also setting a benchmark with its non-contrast imaging solutions. Praising RapidAI’s pioneering role in perfusion imaging for stroke, Dr. Yedavalli highlighted their latest innovation in non-contrast CT imaging. This level of innovation promises to expedite equitable access to advanced technology, thereby addressing the diverse needs of patients worldwide.
RapidAI’s relentless pursuit of innovation and their commitment to improving healthcare through cutting-edge technology positions them at the forefront of transformative change in clinical care delivery, offering hope for enhanced patient outcomes and streamlined healthcare practices globally.
RapidAI’s RSNA 2023 debut marks a pivotal moment in healthcare innovation. With the introduction of Edge Cloud technology, pioneering non-contrast CT imaging solutions, and expansion into Japan, RapidAI sets new benchmarks for global healthcare. Their commitment to advanced AI-driven solutions promises improved patient outcomes, heralding a transformative era in clinical care delivery worldwide.
